–
© AFP
–
The European Commission gave the green light on Wednesday to purchase another 200 million vaccines. These are doses from the American biotech company Novavax. According to Dirk Ramaekers, head of the Vaccination Task Force, this is a new type of vaccine that can be an alternative to the existing one.
–
Farid El Mabrouk
— .
